March 22, 2019AgeX Therapeutics Receives $4.5 Million From Exercise of Warrants
March 21, 2019AgeX Therapeutics to Present at Undoing Aging 2019, March 28-30 in Berlin, Germany
March 07, 2019LifeMap Sciences and iCarbonX Research Shenzhen Announce Strategic Collaboration
January 31, 2019AgeX Therapeutics to Present at Longevity Leaders Conference, February 4 in London
January 22, 2019AgeX Therapeutics’ CEO Dr. Michael D. West Presents at Precision Medicine World Conference 2019
January 10, 2019LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic Partnership to Offer Leading Clinical NGS Solution to the China Market
January 09, 2019AgeX Therapeutics Publishes Data in Peer-Reviewed Journal to Advance Potential Cell Therapy AgeX-BAT1 for Type II Diabetes and Obesity
January 02, 2019AgeX Therapeutics to Present at Biotech Showcase 2019
November 29, 2018AgeX Therapeutics, Inc. to Present Keynote Address at Advanced Stem Cell & Regenerative Medicine 2018 Conference
November 29, 2018AgeX Therapeutics, Inc. Shares Commence Trading on the NYSE American
September 17, 2018BioTime Updates Timeline For Distribution Of AgeX Shares To BioTime Shareholders – Regulatory Approvals In-Process; New Record Date To Be Set Shortly
September 04, 2018BioTime Closes $43.2 Million AgeX Share Sale Transaction With Juvenescence
August 16, 2018AgeX Therapeutics Acquires Technology To Regulate Immune Tolerance – Technology Supports Company’s Strategy For Off-The-Shelf (Allogeneic) Cell-Based Regenerative Medicine Products Through The Use Of The HLA-G Gene
August 02, 2018BioTime To Receive $21.6 Million In Cash And $21.6 Million In A Convertible/Redeemable Note For 14.4 Million Shares Of AgeX Therapeutics. Creates Alignment Between AgeX Therapeutics And Juvenescence Limited To Potentially Become Leader In The Field Of Aging
July 11, 2018AgeX Therapeutics CEO Dr. Michael D. West To Present At Ending Age-Related Diseases: Investment Prospects & Advances In Research, July 12 In New York City
July 10, 2018BioTime Announces July 31, 2018 Record Date For The Distribution Of AgeX Therapeutics Shares
June 11, 2018Agex Therapeutics Closes On $5 Million Strategic Investment From Juvenescence
June 05, 2018Agex Therapeutics Appoints John F. Mauldin To Board Of Directors
May 17, 2018Agex Therapeutics Ceo Dr. Michael D. West To Deliver Keynote Address At World Advanced Therapies & Regenerative Medicine Congress, May 18 In London
May 02, 2018Agex Announces Nih Grant Award
March 01, 2018Agex Therapeutics Ceo Dr. Michael D. West To Present At Three Conferences In March 2018
January 18, 2018Agex Ceo Michael D. West To Present In Plenary Session At The World Stem Cell Summit On “Stem Cell Innovations That Will Change The World”
January 06, 2018Agex Therapeutics To Present At Biotech Showcase Annual Conference
January 02, 2018AgeX Therapeutics Identifies Genes Implicated In Tissue Regeneration And Cancer
December 04, 2017AgeX Therapeutics Ceo Michael D. West To Participate In Roundtable Panel On The Path Forward For Stem Cell Therapy At Termis Americas’ Annual Conference On Tissue Engineering & Regenerative Medicine, December 6 In Charlotte, Nc
November 08, 2017AgeX Therapeutics Vp Of New Technology Discovery Aubrey De Grey To Serve On Aging & Longevity Panel At Ft Global Pharmaceutical And Biotechnology Conference, November 9-10 In London
October 26, 2017AgeX Therapeutics Ceo Michael D. West To Give Special Interview For The Economist’s Conference “The Business Of Longevity: Health Innovation For An Ageing World” October 27 In Hong Kong
September 21, 2017AgeX Therapeutics Ceo Michael D. West To Participate In Fireside Chat With J. Craig Venter At The Cell & Gene Therapy Ceo Forum
August 17, 2017AgeX Therapeutics Closes $10 Million Capital Raise
August 09, 2017AgeX Therapeutics Ceo Michael D. West, Ph.D. To Deliver Keynote Address On Biotechnology And Aging At Raad Festival
August 02, 2017AgeX Therapeutics Obtains $10 Million In Capital And Commences Operations

Sign Up for the Latest AgeX News

Please fill out the form below to stay up-to-date on the latest news, events and pipeline information from AgeX.